EPISODE · Aug 25, 2026 · 13 MIN
HSE approves offer on Skyclarys drug for Friedreich's Ataxia patients
from Lunchtime Live
The HSE today has approved a new offer from drug firm Biogen over ‘Skyclarys’, which will now be available with reimbursement to Friedreich’s Ataxia patients. This comes after mounting pressure, and months of campaigning…Joining Clare McKenna to discuss this is Teresa Kane, a mother of two children with Friedreich’s Ataxia and Niamh Ní Hoireabhaird, who lives with Friedrich’s Ataxia…
Embed this episode
NOW PLAYING
HSE approves offer on Skyclarys drug for Friedreich's Ataxia patients
0:00
13:26
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Lunchtime Live?
This episode is 13 minutes long.
When was this Lunchtime Live episode published?
This episode was published on August 25, 2026.
Can I download this Lunchtime Live episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!